Rabbit Polyclonal SMAD3 antibody. Suitable for IP, WB, IHC-P, ICC/IF and reacts with Human, Mouse samples. Cited in 30 publications.
View Alternative Names
MADH3, SMAD3, Mothers against decapentaplegic homolog 3, MAD homolog 3, Mad3, Mothers against DPP homolog 3, hMAD-3, JV15-2, SMAD family member 3, SMAD 3, Smad3, hSMAD3
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Smad3 antibody (AB84177)
ICC/IF image of ab84177 stained HepG2 cells. The cells were 4% PFA fixed (10 min) and then incubated in 1%BSA / 10% normal Goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab84177, 5µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 Goat anti-Rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM. This antibody also gave a positive result in 4% PFA fixed (10 min) HeLa cells at 5µg/ml.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Smad3 antibody (AB84177)
IHC image of ab84177 staining in Human Cervical carcinoma formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab84177, 1µg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
- IP
Unknown
Immunoprecipitation - Anti-Smad3 antibody (AB84177)
Smad3 was immunoprecipitated using 0.5mg Hela whole cell extract, 5µg of Rabbit polyclonal to Smad3 and 50µl of protein G magnetic beads (+). No antibody was added to the control (-).
The antibody was incubated under agitation with Protein G beads for 10min, Hela whole cell extract lysate diluted in RIPA buffer was added to each sample and incubated for a further 10min under agitation.
Proteins were eluted by addition of 40µl SDS loading buffer and incubated for 10min at 70oC; 10µl of each sample was separated on a SDS PAGE gel, transferred to a nitrocellulose membrane, blocked with 5% BSA and probed with ab84177.
Secondary : Mouse monoclonal [SB62a] Secondary Antibody to Rabbit IgG light chain (HRP) (ab99697).
Band : 50kDa : Smad3
All lanes:
Immunoprecipitation - Anti-Smad3 antibody (ab84177)
Predicted band size: 48 kDa
false
- WB
Lab
Western blot - Anti-Smad3 antibody (AB84177)
Lanes 1 - 2 : Merged signal (red and green). Green - ab84177 observed at 50 kDa. Red - loading control ab8245 (Mouse anti-GAPDH antibody [6C5]) observed at 37kDa.
ab84177 was shown to react with Smad3 in wild-type A549 cells in western blot with loss of signal observed in SMAD3 knockout sample. Wild-type and SMAD3 knockout A549 cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3% milk in TBS-T (0.1% Tween®) before incubation with ab84177 and ab8245 (Mouse anti-GAPDH antibody [6C5]) overnight at 4°C at 1 μg/ml and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Smad3 antibody (ab84177) at 1 µg/mL
Lane 1:
Wild-type A549 (Human lung carcinoma cell line) whole cell lysate at 20 µg
Lane 2:
SMAD3 knockout A549 (Human lung carcinoma cell line) whole cell lysate at 20 µg
Lane 2:
Western blot - Human SMAD3 knockout A549 cell lysate (<a href='/en-us/products/cell-lysates/human-smad3-knockout-a549-cell-lysate-ab264513'>ab264513</a>)
Predicted band size: 48 kDa
Observed band size: 50 kDa
false
- WB
Unknown
Western blot - Anti-Smad3 antibody (AB84177)
All lanes:
Western blot - Anti-Smad3 antibody (ab84177) at 1 µg/mL
Lane 1:
HeLa (Human epithelial carcinoma cell line) Nuclear Lysate at 10 µg
Lane 2:
HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate at 10 µg
Lane 3:
NIH 3T3 (Mouse embryonic fibroblast cell line) Whole Cell Lysate at 10 µg
Secondary
All lanes:
Goat polyclonal Secondary Antibody to Rabbit IgG - H&L (HRP), pre-adsorbed at 1/5000 dilution
Predicted band size: 48 kDa
Observed band size: 37 kDa,48 kDa,50 kDa
true
Exposure time: 8min
- WB
Unknown
Western blot - Anti-Smad3 antibody (AB84177)
All lanes:
Western blot - Anti-Smad3 antibody (ab84177) at 1 µg/mL
Lane 1:
A431 (Human epithelial carcinoma cell line) Whole Cell Lysate at 10 µg/mL
Lane 2:
EGF-treated A431 (Human epithelial carcinoma cell line) Whole Cell Lysate at 10 µg/mL
Secondary
All lanes:
Goat polyclonal to Rabbit IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution
Predicted band size: 48 kDa
Observed band size: 52 kDa
true
Exposure time: 20min
- WB
CiteAb
Western blot - Anti-Smad3 antibody (AB84177)
Smad3 western blot using anti-Smad3 antibody ab84177. Publication image and figure legend from Yin, L., Hu, Y., et al., 2017, Front Immunol, PubMed 28217129.
ab84177 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab84177 please see the product overview.
Protein detection by using ELISA analysis, Western blot, and flow cytometry. (A) ELISA analysis shows significant TGF-β1 protein secretion in supernatant in both UVB and IL-17A/TNF-α + UVB groups. (B) Western blot shows the protein expression of Smad3 is significantly upregulated in both UVB and IL-17A/TNF-α + UVB groups. (C) Flow cytometry shows P144 (2 μg/ml) is able to block the inhibitory effect of UVB on the expression of IL-17RA and IL-17RC on HDFs. The data (fold change) of Western blot are expressed as the mean ± SD of three independent experiments. Other data are from one representative experiment performed in triplicate, repeated three times with similar results. UVB, ultraviolet B; HDFs, human dermal fibroblasts. Statistical significance indicated : *p < 0.05, **p < 0.01.
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Smad3 acts as a mediator of signal transduction for the TGF-beta (transforming growth factor-beta) superfamily forming a complex with phosphorylated Smad2. This enables it to regulate transcriptional activity influencing cell proliferation differentiation and apoptosis. Smad3 also participates in various cellular processes by interacting with other co-factors and regulatory proteins that aid in fine-tuning its function.
Pathways
Smad3 plays an important role in the TGF-beta signaling pathway where it works closely with Smad4 to propagate the signal. Upon phosphorylation it forms a complex with co-Smad (Smad4) and moves into the nucleus to influence gene expression. Smad3 is also involved in pathways related to oncogenesis and tissue fibrosis indicating its significant role in cellular regulation and response mechanisms.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (30)
Recent publications for all applications. Explore the full list and refine your search
BMC nephrology 26:526 PubMed41013408
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell division 20:20 PubMed40751214
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of thoracic disease 17:4238-4248 PubMed40688289
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of endocrinology 2025:1394709 PubMed40486272
2025
Applications
Unspecified application
Species
Unspecified reactive species
Science advances 11:eadr7208 PubMed40203118
2025
Applications
Unspecified application
Species
Unspecified reactive species
Allergologia et immunopathologia 52:91-96 PubMed38970271
2024
Applications
Unspecified application
Species
Unspecified reactive species
Molecular biology of the cell 35:ar35 PubMed38170570
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 14:816 PubMed38086793
2023
Applications
Unspecified application
Species
Unspecified reactive species
Heliyon 9:e21220 PubMed37920527
2023
Applications
Unspecified application
Species
Unspecified reactive species
Phytotherapy research : PTR 38:1745-1760 PubMed37740455
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com